Black Diamond Therapeutics Inc
NASDAQ:BDTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Black Diamond Therapeutics Inc
NASDAQ:BDTX
|
US |
|
Corporate Travel Management Ltd
ASX:CTD
|
AU |
|
S
|
SAB Finance as
PSE:SABFG
|
CZ |
|
Labrador Iron Ore Royalty Corp
TSX:LIF
|
CA |
|
T
|
Thai Oil PCL
SET:TOP
|
TH |
|
C
|
Commerce Miner Co Ltd
KOSDAQ:223310
|
KR |
|
T
|
Tandy Leather Factory Inc
NASDAQ:TLF
|
US |
|
CoStar Group Inc
NASDAQ:CSGP
|
US |
|
PennyMac Mortgage Investment Trust
NYSE:PMT
|
US |
|
Rotork PLC
LSE:ROR
|
UK |
|
Duckyang Industry Co Ltd
KRX:024900
|
KR |
|
Vystar Corp
OTC:VYST
|
US |
Wall Street
Price Targets
BDTX Price Targets Summary
Black Diamond Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
BDTX
is 9.909 USD
with a low forecast of 7.07 USD and a high forecast of 14.7 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is BDTX's stock price target?
Price Target
9.909
USD
According to Wall Street analysts, the average 1-year price target for
BDTX
is 9.909 USD
with a low forecast of 7.07 USD and a high forecast of 14.7 USD.